BR0009101A - 9a-azalidas com atividade antibacteriana - Google Patents

9a-azalidas com atividade antibacteriana

Info

Publication number
BR0009101A
BR0009101A BR0009101-4A BR0009101A BR0009101A BR 0009101 A BR0009101 A BR 0009101A BR 0009101 A BR0009101 A BR 0009101A BR 0009101 A BR0009101 A BR 0009101A
Authority
BR
Brazil
Prior art keywords
formula
azalides
antibacterial activity
compounds
processes
Prior art date
Application number
BR0009101-4A
Other languages
English (en)
Inventor
Yat Sun Or
Robert F Keyes
Zhenkun Ma
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of BR0009101A publication Critical patent/BR0009101A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Saccharide Compounds (AREA)

Abstract

"9A-AZALIDAS COM ATIVIDADE ANTIBACTERIANA". Compostos de fórmula (I), fórmula (II), fórmula (III), e fórmula (IV) ou sais farmaceuticamente aceitáveis ou drogas destes, são agentes antibacterianos. São descritos composições contendo os compostos, processos para fazer os compostos, intermediários sintéticos empregados nos processos, e métodos para tratamento e prevenção das infecções bacterianas.
BR0009101-4A 1999-08-24 2000-07-26 9a-azalidas com atividade antibacteriana BR0009101A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US38216699A 1999-08-24 1999-08-24
PCT/US2000/020363 WO2001014397A1 (en) 1999-08-24 2000-07-26 9a-azalides with antibacterial activity

Publications (1)

Publication Number Publication Date
BR0009101A true BR0009101A (pt) 2002-02-05

Family

ID=23507795

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0009101-4A BR0009101A (pt) 1999-08-24 2000-07-26 9a-azalidas com atividade antibacteriana

Country Status (15)

Country Link
EP (1) EP1206476B1 (pt)
JP (1) JP2003507487A (pt)
AR (1) AR025379A1 (pt)
AT (1) ATE315042T1 (pt)
AU (1) AU6748500A (pt)
BR (1) BR0009101A (pt)
CA (1) CA2380455C (pt)
CY (1) CY1104996T1 (pt)
DE (1) DE60025370T2 (pt)
DK (1) DK1206476T3 (pt)
ES (1) ES2256030T3 (pt)
HK (1) HK1047940B (pt)
MX (1) MXPA02001897A (pt)
PT (1) PT1206476E (pt)
WO (1) WO2001014397A1 (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0127349D0 (en) 2001-11-14 2002-01-02 Glaxo Group Ltd Macrolides
US6764998B1 (en) 2003-06-18 2004-07-20 Enanta Pharmaceuticals, Inc. 6,11-4C-bicyclic 9a-azalide derivatives
US7135573B2 (en) 2002-05-13 2006-11-14 Enanta Pharmaceuticals, Inc. Processes for the preparation of O-(6-Pyrazol-1-yl-pyridin-3-ylmethyl)-hydroxylamine
US7022679B2 (en) 2002-05-13 2006-04-04 Enanta Pharmaceuticals, Inc. Processes for the preparation of 6-11 bicyclic erythromycin derivatives
US7910558B2 (en) 2002-05-13 2011-03-22 Enanta Pharmaceuticals, Inc. Bridged macrocyclic compounds and processes for the preparation thereof
US6645941B1 (en) 2003-03-26 2003-11-11 Enanta Pharmaceuticals, Inc. 6,11-3C-bicyclic 9a-azalide derivatives
WO2005030227A1 (en) 2003-09-23 2005-04-07 Enanta Pharmaceuticals, Inc. 9a, 11-3C-BICYCLIC 9a-AZALIDE DERIVATIVES
WO2005070113A2 (en) 2004-01-09 2005-08-04 Enanta Pharmaceuticals, Inc. 9n-substituted 6-11 bicyclic erythromycin derivatives
CN111825733A (zh) * 2013-04-04 2020-10-27 哈佛大学的校长及成员们 大环内酯及其制备和使用方法
CN106998685A (zh) 2014-10-08 2017-08-01 哈佛大学的校长及成员们 14‑元酮内酯及其制备和使用方法
CN107530365A (zh) 2015-03-25 2018-01-02 哈佛大学的校长及成员们 具有修饰的脱氧糖胺糖的大环内酯及其用途

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA835204B (en) * 1982-07-19 1985-02-27 Pfizer N-methyl 11-aza-10-deoxo-10-dihydroerythromycin a,intermediates therefor and processes for their preparation
US4474768A (en) * 1982-07-19 1984-10-02 Pfizer Inc. N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor
PH19293A (en) * 1982-11-15 1986-03-04 Pfizer Epimeric azahomoerythromycin,pharmaceutical composition containing the same and method of use thereof
YU44599B (en) * 1986-09-12 1990-10-31 Pliva Pharm & Chem Works Process for preparing complex of n-methyl-11-aza-10-deoxo-10-dihydroeritromicine a and 11-aza-10-deoxo-10-dihydroeritromicine a with metals
DE69403963T2 (de) * 1993-05-19 1997-11-20 Pfizer Zwischenprodukt für azithromycin
HN1998000074A (es) * 1997-06-11 1999-01-08 Pfizer Prod Inc Derivados de macrolidos c-4 sustituidos
HN1998000086A (es) * 1997-06-11 1999-03-08 Pfizer Prod Inc Derivados de 9 - desofo - 9 aza - 9a - homoeritromicina a - c - 4 sustituidos.
AU7961498A (en) * 1997-06-26 1999-01-19 Merck & Co., Inc. 9a-azalides, compositions containing such compounds and methods of treatment
AU7986098A (en) * 1997-06-27 1999-01-19 Merck & Co., Inc. 9a-aza-3-ketolides, compositions containing such compounds and methods of treatment
EP1101769A3 (en) * 1999-11-18 2001-10-24 Pfizer Products Inc. Nitrogen containing erythromycin derivatives

Also Published As

Publication number Publication date
DE60025370T2 (de) 2006-09-21
HK1047940A1 (en) 2003-03-14
ATE315042T1 (de) 2006-02-15
ES2256030T3 (es) 2006-07-16
PT1206476E (pt) 2006-05-31
EP1206476A1 (en) 2002-05-22
JP2003507487A (ja) 2003-02-25
CY1104996T1 (el) 2010-03-03
CA2380455A1 (en) 2001-03-01
HK1047940B (zh) 2006-11-03
MXPA02001897A (es) 2002-10-31
DK1206476T3 (da) 2006-05-15
DE60025370D1 (de) 2006-03-30
EP1206476B1 (en) 2006-01-04
AR025379A1 (es) 2002-11-20
WO2001014397A1 (en) 2001-03-01
CA2380455C (en) 2009-06-02
AU6748500A (en) 2001-03-19

Similar Documents

Publication Publication Date Title
BR0000003A (pt) Azalidas e métodos de preparação das mesmas
BR0014078A (pt) Inibidores de fator xa
AU6339599A (en) Quinoline derivatives and their use as antibacterial agents
BR0112750A (pt) Aminopiperidina quinolinas e seus análogos azaisostéricos com atividade antibacteriana
BRPI0113331B8 (pt) derivados de fenilalanina ou seus sais parmaceuticamente aceitáveis, antagonista de integrina alfa 4, agente terapêutico ou agente preventivo para doenças inflamatórias, e, composição farmacêutica
BRPI9810519A (pt) derivados de 4''-substituído-9-desoxo-9a-aza-9a-homoeritromicina a e composição farmacêutica compreendendo os mesmos.
BR9606547A (pt) Novos derivados de pirimidona com atividade fungicida
BR0109703A (pt) Derivados de piperazina
HRP20060275A2 (en) 6-0-supstituted ketolides having antibacterial activity
IL127965A0 (en) Pentafluorobenzenesulfonamide derivatives analogs thereof and pharmaceutical compositions containing the same
BR9909994A (pt) Quinolinas usadas como inibidores de mrs e bactericidas
BG106366A (en) Moxifloxacin formulation containing common salt
TR200200883T2 (tr) 2-ikameli 1,1-bifenil-2-karbonamidler, imalat yöntemleri, ilaç olarak kullanılmaları
SE9900961D0 (sv) Novel compounds
BRPI9915480B8 (pt) azalídeos de 13 membros, composições farmacêuticas compreendendo os mesmos, método para sua preparação bem como seus usos.
CY1104996T1 (el) 9α-αζαλιδια εχοντα αντιβακτηριακην δρασιν
BR9813319A (pt) Composto, composição farmacêutica para tratamento de infecções bacterianas, e, processos para tratar infecções bacterianas e para preparar um composto
SE9802208D0 (sv) Novel compounds
BR9812577A (pt) Composto, processo para preparar o mesmo, composição farmacêutica, e, processo para tratar infecções bacterianas
TR199900661T2 (xx) Cilt enfeksiyonlar�n�n tedavisi amac�yla 1-hidroksi-2-piridonlar�n kullan�m�
BR0309878A (pt) Heterotriciclil-6-alquilideno-penemas como inibidores de beta-lactamase
ATE165101T1 (de) Basische prolinamid derivate von ge2270 und ge2270-ahnlichten antibiotika
ES2178301T3 (es) Derivados del acido penicilanico 2-beta-sustituido-6-alquilideno como inhibidores de la beta-lactama.
BR0315106A (pt) Derivados antimicrobianos de [3.1.0]oxazolidinona bicìclica
SE9802209D0 (sv) Novel compounds

Legal Events

Date Code Title Description
FA10 Dismissal: dismissal - article 33 of industrial property law
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]